In this study, we investigated the anti-tumor effect of several dual inhibitors of HDACs and GSK3B on ovarian cancer cell proliferation, migration, and invasion in vitro in human and mouse ovarian cancer cell lines and identified the Metavert analog APCS-540 as the most effective compound against ovarian cancer compared to other Metavert analogs. Here, GSK3B is linked to ovarian cancer.